<strong>The Effects of Tenuigenin on Expression of nAChRα4 and PSD95 in Alzheimer’s Disease Model Rats</strong>

Abstract

Abstract:Objective：To investigate the effects and the underlying mechanisms of Tenuigenin on Alzheimer’s disease by observing the effects of Tenuigenin(TEN) on expression of nicotinic acetylcholine receptor subunit alpha-4 (nAChRα4) and postsynaptic density 95(PSD-95) in Alzheimer’s disease model rat.Methods：32 male Wistar rats were divided randomly into four groups: control group，model group，12.5 mg·mL^-1dose TEN group and 37.5 mg·mL^-1dose TEN group. The rat model with Alzheimer’s disease was made by injecting ibotenic acid into Meynert basal nuclei of aging rat induced by D-gal.The expressions of nAChRα4 and PSD-95 in the hippocampus CA1 were measured by immunohistochemistry method.Results：Compared with the control group，the average gray-scale values of hippocampus CA1 nAChRα4 and PSD-95 in the model group were increased significantly and the average optical density was decreased obviously (P<0.01). Compared with the model group，the average gray-scale values in the hippocampus CA1 of 37.5 mg·mL^-1dose TEN group and 12.5 mg·mL^-1dose TEN group were obviously decreased and the average optical density was increased significantly (P<0.05). Meanwhile，the average gray-scale value within the hippocampus CA1 of 37.5 mg·mL^-1dose TEN group was significantly less than that in 12.5 mg·mL^-1dose TEN group，but more distinct than that on the average optical density aspect (P<0.01).Conclusion：TEN can dose-dependently increase the expression of CA1 area nAChRα4 and PSD-95 in Alzheimer’s disease model rats，which may partly explain the beneficial effects of TEN on cognitive function.

Key words:Tenuigenin,Alzheimer&,rsquo,s disease,hippocampus,nAChR&,alpha,4,PSD-95

CLC Number:

R961

Li Xiao-feng, Zhao Da-peng, Chen Shu-sha, Jing Wei, Li Xin-yi.The Effects of Tenuigenin on Expression of nAChRα4 and PSD95 in Alzheimer’s Disease Model Rats[J]. ACTA NEUROPHARMACOLOGICA, 2011, 1(3): 16-22.

References

1 Yuki Takada-Takatori，Toshiai Kume，Yasuhiko Izumi，et al. Roles of nicotinic receptors in acetylcholinesterase inhibitor-induced neuroprotection and nicotinicreceptor up-regulation [J]. Biol Pharm Bull，2009，32(3):318-324
2 Guan Zhizhong，Zhang Xiao，Ravid Ravid，Nordberg Agneta. Decreased protein levels of nicotinic Receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer’s disease [J]. J Neurochem，2000，74 (1):237-243
3 Mary B Kennedy .Signal-processing machines at the postsynaptic density[J]. Science.2000，290(5492):750-754
4 陈勤，高晨曦，葛礼浩，陈小峰.远志皂苷对脑定位注射Aβ1-40拟AD大鼠脑内神经形态病理学变化的影响[J].激光生物学报，2006，15(3):294-298
5 谢宁，柳琳，周妍妍，何秀丽，邹纯朴.地黄饮子对老年性痴呆模型大鼠脑组织NO、NOS含量及行为学的影响[J].中国中医药科技，2004，3(11):84-85
6 郭宇飞，李新毅，郭芬，曹杜娟.中药远志对D-半乳糖致衰大鼠学习记忆及海LTP的影响[J].中国老年学杂志，2011，31(4):632-634
7 关彩宣，孙妠，曲鹏，张朝东. 鹅膏蕈氨酸对大鼠海马神经元的毒性作用[J].中国公共卫生，2006，22(9):1115-1116
8 Steven D.Buckingham ，Andrew K.Jones ，Laurence A.Brown ，David B.Sattelle . Nicotinic acetylcholine receptor signaling: roles in Alzheimer’s disease and amyloid neuroprotection[J].Pharmacol Rev，2009，61(1):39-61
9 Antoine Taly，Pierre-Jean Corringer ，Denis Guedin，Pierre Lestage，Jean-Pierre Changeux . Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system [J]. Nat Rev Drug Discov.2009，8(9):733-750
10 Outi Salminen，Karen L.Murphy，J.Michael McIntosh，et al. Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice [J]. Mol Pharmacol 2004，65(6):1526-1535
11 Ana Pocivavsek，Laura Icenogle，Edward D Levin. Ventral hippocampal alpha7 and alpha4beta2 nicotinic receptor blockade and clozapine effects on memory in female rats [J]. Psychopharmacology (Berl).2006，188(4):597-604
12 Paul D.Coleman，Pamela J.Yao. Synaptic slaughter in Alzheimer’s disease [J]. Neurobiol Aging，2003，24(8):1023-1027
13 侯筱宇，张光毅.NMDA受体信号复合体中蛋白质的相互作用[J].生命科学，2003，15(5):274-278
14 Martine Migaud ，Paul Chatlesworth，Maureen Dempster，et al. Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein [J].Nature，1998，396(6710):433-439
15 吴伯智，谢珣，赵冬芹，蔡昭林，杨美燕，李楚华.远志皂苷对小鼠行为习得及海马CA3区突触形态的影响[J].华南师范大学学报，2011，2(1):111-115
16 陈庆林，陈勤，金蓓蓓.远志皂苷对AD小鼠学习记忆能力及中枢胆碱能系统标志酶活性的影响[J].中药药理与临床，2011，27(3):33-36

[1]	XIE bin, HUANG Zhi-yuan, LIN Duo-duo, YANG Fu-long, XIE Yi-bin.Effect of Acupuncture Combined with Medicine on Depressive Symptoms of Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 5-8.
[2]	SUN Li-cong, ZHANG Dan-shen.Research Progress on Potential Treatment of Alzheimer’s Disease with Alkaloids[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 33-37.
[3]	WANG Si-yi, LI Xian-xiang, LIU Yi-zhou, DU Shuang, GE Chao, LIU Si-si.Current Situation and Prospect of Alzeimer’s Disease Treatment[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 38-42.
[4]	ZHAO Yu-wei, ZHEN Yan-jie, DAI Yue-ying, SHEN Li-xia.Study on the Neuroprotective Mechanism of Quercetin in Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 55-64.
[5]	LI Lan, ZHANG Dan-shen.Research Methods of Drug in Vitro Liver Metabolism[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(4): 10-13.
[6]	HAI Ji-tao, LUO Huan-min.Progress on the Relationship between Pathogenic Microorganisms and Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(4): 58-64.
[7]	ZHANG Hao-ting, SONG Gui-qin, CUI Ruo-tong, HAO Min, WANG Wen-dong.Mining Target Genes of Alzheimer’s Disease Associated with Biological Clock by Bioinformatics Analysis[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 1-7.
[8]	YANG Xu-hua, DU Shuang, SHEN Li-xia, HAO Jun-rong.Research Progress in Drug Treatment of Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 47-53.
[9]	XIONG Meng-yao, JIA Ying-li, YANG Bao-xue.Relationship between Prostaglandin Receptor EP4 and Renal Diseases[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 54-64.
[10]	ZHEN Yan-jie, GUO Tong-lin, ZHAO Yu-wei, SHEN Li-xia.Study Progress on Phytoestrogen-Mediated Mitochondrial Pathway’s Neuroprotective Effects in Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(1): 40-46.
[11]	ZHANG Qun-feng，HE Huan-ying，LIAO Yun-hao，WANG Guo-qing.The Effects of Maternal Chlorpyrifos Exposure on the Expression of COX2，CREB and BDNF in Hippocampus of Offspring Mice[J]. Acta Neuropharmacologica, 2019, 9(6): 1-5.
[12]	WU Chun-yang，MA Jia-cheng，ZHANG Nan，et al.Batch Determination of Amino Acid Neurotransmitters and Taurine in Mouse Cortex and Hippocampus by Amino Acid Analyzer[J]. Acta Neuropharmacologica, 2019, 9(5): 10-16.
[13]	YANG-Lin，AI-Jing.Research Progress of Brain-Derived Estrogen in Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2019, 9(5): 50-64.
[14]	ZHANG Shuai，AI Jing.Glutamate Dysfunction and Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2018, 8(6): 9-20.
[15]	王奇.Bushen-Yizhi Formula Inhibits the NLRP3/NFκB Mediated Neuroinflammation and Improves the Motor Dysfunction in a Mouse Model of Parkinson's Disease[J]. Acta Neuropharmacologica, 2018, 8(5): 71-72.

The Effects of Tenuigenin on Expression of nAChRα4 and PSD95 in Alzheimer’s Disease Model Rats

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics